{"id":"metronidazole-400-7-days","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Metallic taste"},{"rate":"5-10","effect":"Nausea"},{"rate":"2-5","effect":"Headache"},{"rate":"2-5","effect":"Diarrhea"},{"rate":"1-2","effect":"Peripheral neuropathy (with prolonged use)"},{"rate":null,"effect":"Disulfiram-like reaction with alcohol"}]},"_chembl":null,"_fixedAt":"2026-03-30T17:41:01.982913","_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metronidazole is a prodrug that requires reduction by anaerobic organisms or parasites to form reactive intermediates that damage DNA and inhibit nucleic acid synthesis. It is effective against anaerobic bacteria and certain protozoan parasites, making it bactericidal and antiprotozoal. The drug has been in clinical use for decades and is considered a first-line agent for anaerobic infections and specific parasitic diseases.","oneSentence":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after being reduced inside microbial cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:55:05.757Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anaerobic bacterial infections (e.g., intra-abdominal, gynecological, dental)"},{"name":"Trichomoniasis"},{"name":"Giardiasis"},{"name":"Amebiasis"},{"name":"Clostridioides difficile infection"},{"name":"Bacterial vaginosis"}]},"_fixedFields":["pubmed(123)"],"trialDetails":[{"nctId":"NCT03304587","phase":"NA","title":"Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors","status":"COMPLETED","sponsor":"Michigan State University","startDate":"2017-11-06","conditions":"Breast Cancer","enrollment":30},{"nctId":"NCT05934227","phase":"NA","title":"Amoxicillin Plus Metronidazole in Periodontal Maintenance","status":"COMPLETED","sponsor":"Federal University of Minas Gerais","startDate":"2023-07-01","conditions":"Periodontitis, Periodontal Pocket","enrollment":50},{"nctId":"NCT05462496","phase":"PHASE2","title":"Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2023-03-16","conditions":"Pancreatic Cancer","enrollment":25},{"nctId":"NCT02373280","phase":"NA","title":"The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-08","conditions":"Helicobacter Infection","enrollment":600},{"nctId":"NCT02359331","phase":"NA","title":"The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection","status":"TERMINATED","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-08","conditions":"Helicobacter Infection","enrollment":370},{"nctId":"NCT02185209","phase":"PHASE4","title":"Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics","status":"COMPLETED","sponsor":"Margareta Hultin","startDate":"2015-03","conditions":"Periodontal Diseases, Periimplantitis","enrollment":77},{"nctId":"NCT03163602","phase":"NA","title":"Surgical Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"The University of Western Australia","startDate":"2017-05-15","conditions":"Peri-Implantitis","enrollment":40},{"nctId":"NCT03656328","phase":"NA","title":"Supplementation With Lacobacillus Reuteri ATCC PTA 4659 in Patients Affected by Acute Uncomplicated Diverticulitis","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2018-04-01","conditions":"Acute Diverticulitis","enrollment":90},{"nctId":"NCT02969928","phase":"PHASE2, PHASE3","title":"Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis","status":"COMPLETED","sponsor":"Universidade Estadual Paulista Júlio de Mesquita Filho","startDate":"2015-03","conditions":"Aggressive Periodontitis","enrollment":46},{"nctId":"NCT03383120","phase":"NA","title":"Diode Laser for Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"University of Geneva, Switzerland","startDate":"2017-10-10","conditions":"Peri-Implantitis, Implant Complication","enrollment":40},{"nctId":"NCT03099408","phase":"PHASE4","title":"Oral Metronidazole With Lactobacillus Vaginal Suppositories to Prevent Recurrence of Bacterial Vaginosis","status":"COMPLETED","sponsor":"Peking University Shenzhen Hospital","startDate":"2017-07-01","conditions":"Bacterial Vaginosis, Recurrence","enrollment":66},{"nctId":"NCT03236961","phase":"NA","title":"Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Turku University Hospital","startDate":"2017-04-03","conditions":"Acute Appendicitis","enrollment":552},{"nctId":"NCT03257423","phase":"NA","title":"Acute Appendicitis and Microbiota - Etiology of Appendicitis and Antibiotic Therapy Effects","status":"UNKNOWN","sponsor":"Turku University Hospital","startDate":"2017-04-04","conditions":"Acute Appendicitis","enrollment":200},{"nctId":"NCT03563586","phase":"NA","title":"Mechanical Bowel Preparation With or Without Oral Antibiotics for Colorectal Cancer Surgery","status":"UNKNOWN","sponsor":"National and Kapodistrian University of Athens","startDate":"2018-04-01","conditions":"Antibiotic, Bowel Cancer, Colorectal Cancer","enrollment":210},{"nctId":"NCT04353362","phase":"PHASE4","title":"Alternative Antibiotic Regimen in Periodontitis Treatment","status":"COMPLETED","sponsor":"Istanbul Medipol University Hospital","startDate":"2017-04-01","conditions":"Amoxicillin, Metronidazole, Ofloxacin","enrollment":74},{"nctId":"NCT02735395","phase":"PHASE4","title":"Dose and Duration of Metronidazole and Amoxicillin for Treatment of Chronic Periodontitis","status":"UNKNOWN","sponsor":"University of Guarulhos","startDate":"2011-07","conditions":"Chronic Periodontitis","enrollment":110},{"nctId":"NCT02839421","phase":"PHASE4","title":"Efficacy of Three Antibiotic Protocols for Aggressive Periodontitis Treatment","status":"UNKNOWN","sponsor":"Facultad Nacional de Salud Publica","startDate":"2015-12","conditions":"Aggressive Periodontitis","enrollment":36},{"nctId":"NCT03219723","phase":"","title":"Drug Use Surveillance of Takecab for \"Supplement to Helicobacter Pylori Eradication\"","status":"COMPLETED","sponsor":"Takeda","startDate":"2015-09-01","conditions":"Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other","enrollment":560},{"nctId":"NCT02223702","phase":"PHASE4","title":"Alternative Antibiotic Regime in the Treatment of GAgP","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2011-05","conditions":"Generalized Aggressive Periodontitis, Aggressive Periodontitis","enrollment":39},{"nctId":"NCT03132714","phase":"PHASE2, PHASE3","title":"Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive Periodontitis","status":"COMPLETED","sponsor":"Universidade Estadual Paulista Júlio de Mesquita Filho","startDate":"2015-03","conditions":"Aggressive Periodontitis, Generalized","enrollment":46},{"nctId":"NCT01264822","phase":"","title":"Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Eisai Co., Ltd.","startDate":"2011-01-13","conditions":"Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive","enrollment":108},{"nctId":"NCT03043066","phase":"NA","title":"Serum TRAP-5b Levels in Patients With Generalized Chronic Periodontitis","status":"COMPLETED","sponsor":"Meenakshi Ammal Dental College and Hospital","startDate":"2016-03-01","conditions":"Chronic Periodontitis","enrollment":30},{"nctId":"NCT00707369","phase":"PHASE4","title":"Adjunctive Antimicrobial Therapy of Periodontitis: Long-Term Effects on Disease Progression and Oral Microbiological Colonization","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2008-10","conditions":"Periodontitis","enrollment":540},{"nctId":"NCT01153958","phase":"PHASE4","title":"Colposeptine for the Treatment of Bacterial Vaginosis","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2010-07","conditions":"Vaginosis, Bacterial","enrollment":133},{"nctId":"NCT00805558","phase":"PHASE4","title":"Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole on Patients With Chronic Periodontitis","status":"COMPLETED","sponsor":"Facultad Nacional de Salud Publica","startDate":"2009-02","conditions":"Chronic Periodontitis","enrollment":76}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":123,"recentPublications":[{"date":"2026 Jan 30","pmid":"41750436","title":"Multi-Species Synbiotic Supplementation After Antibiotics Promotes Recovery of Microbial Diversity and Function, and Increases Gut Barrier Integrity: A Randomized, Placebo-Controlled Trial.","journal":"Antibiotics (Basel, Switzerland)"},{"date":"2026 Feb","pmid":"41694406","title":"Vonoprazan-Containing Triple Therapy Based on Clarithromycin Susceptibility May Be Definitive Treatment Strategy for Eradication of Helicobacter pylori.","journal":"JGH open : an open access journal of gastroenterology and hepatology"},{"date":"2025 Aug","pmid":"40844182","title":"Eradication of Helicobacter pylori for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCT.","journal":"Health technology assessment (Winchester, England)"},{"date":"2025 Apr 23","pmid":"40314214","title":"Effectiveness of oral probiotics and metronidazole compared with oral probiotics and metronidazole pessaries in the treatment of bacterial vaginosis in Chinese women.","journal":"African journal of reproductive health"},{"date":"2025 Mar 6","pmid":"40043236","title":"Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis.","journal":"The New England journal of medicine"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Metronidazole 400 (7 days)","genericName":"Metronidazole 400 (7 days)","companyName":"University of Guarulhos","companyId":"university-of-guarulhos","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metronidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after being activated in anaerobic environments. Used for Bacterial vaginosis, Trichomoniasis, Anaerobic bacterial infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}